HANSEN-TECHNOLOGIES
7.12.2021 12:02:06 CET | Business Wire | Press release
Hansen Technologies (ASX:HSN) is pleased to announce that Vodafone Cook Islands is now live with Hansen CCB , part of the Hansen Suite for Communications Service Providers (CSPs) . Hansen CCB, a tailor-made billing solution leveraging Microsoft Dynamics 365 Business Central, delivers end-to-end ‘Business in a Box’ ERP capability for CSPs around the world. Vodafone now joins Hansen’s family of over 600 global customers.
Vodafone Cook Islands was looking to replace its legacy finance and billing systems with a single application, suitable for their direct, local customer base and which could also cater to their relatively large volume of short-term tourist contracts. Being a remote location, the need for a self-managed solution with extensive configuration capability, browser-based interfaces, modern integrations and demonstrated market experience was essential.
Hansen CCB allows CSPs to implement and bill new communications services rapidly, and also enables the delivery of fixed and mobile telephony services, broadband services, IPTV, content packages and bundled offers. Through its integration with Microsoft’s business management and ERP software, Hansen CCB provides a unified business platform, reducing the cost and operational complexity associated with operating and maintaining disparate software systems.
Phillip Henderson, Chief Executive Officer, Vodafone Cook Islands, commented: “At Vodafone Cook Islands, we were impressed with the expertise of the Hansen team from the outset. They demonstrated their extensive track record of spearheading digital transformation for CSPs worldwide with a very successful implementation on time and on budget – delivered completely remotely at the height of the global pandemic. We are excited about the feature-rich capability and flexibility of the Hansen solution, and have already realised significant process improvements following our go-live earlier in July.”
David Castree, Regional President for the Asia-Pacific region and Head of Global Partnerships, Hansen Technologies, commented : “With the addition of Hansen CCB, Vodafone’s resources will be able to actively focus on business growth, rather than managing the complexities of their previous solutions. Our solution, with its ability to support a broad range of communication products, allows smaller network operators like Vodafone Cook Islands the flexibility to create new products and deliver services – while improving the customer experience through consistent, high-quality interaction. At Hansen, we also know that with transformation initiatives such as this, skill and knowledge transfer are imperative. Hansen worked closely (albeit remotely through COVID-19) with Vodafone Cook Islands to ensure that the business continued to enjoy a high degree of confidence during its journey.”
The Hansen Suite for CSPs enables service providers to create and deliver new business models through accelerated product innovation. Hansen CCB provides flexible rating, billing and customer care for communications service providers.
For further information about Hansen, please visit www.hansencx.com .
About Hansen Technologies
Hansen Technologies (ASX: HSN) is a leading global provider of software and services to the energy, water and communications industries. With its award-winning software portfolio, Hansen serves 600+ customers in over 80 countries, helping them to create, sell, and deliver new products and services, manage and analyse customer data, and control critical revenue management and customer support processes.
For more information, visit www.hansencx.com
About Vodafone Cook Islands
Vodafone Cook Islands is the leading telecommunications services provider in the Cook Islands offering mobile, broadband, fixed line and a range of other telecommunications technology based services across all inhabited islands. The Company also provides these community services on behalf of the Government – Pa Enua services, broadcasting support services, marine radio services and postal services.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211207005075/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom